The key to establishing a cycle of discovery is establishing a proper, formally structured systematic approach to treatment that aims to understand the reasons for treatment failure.
Cost-effectiveness analysis should incorporate net health improvement and a dollar threshold for quality-adjusted life-years, according to some experts.
A team of investigators recommends that clinicians prepare to discuss long-term affordability and relative efficacy of biologic DMARDS with their patients with RA, as out-of-pocket costs are expected to reach a “catastrophic” phase of coverage.
The RNS has announced the publication of a new textbook, new live events, and other important projects.
The government mandate to transition to electronic health records (EHRs) affects large institutions and private practitioners alike.
The general media and the medical press have reported on the growing shortage of physicians.
As the era of the Medicare Access and CHIP Reauthorization Act (MACRA) begins, physicians must think about choosing 1 of 2 reimbursement systems that will go into effect in 2019.
Speakers at the annual meeting of the Healthcare Information and Management Systems Society offered advice to physicians as they prepare to implement ICD-10.
Telemedicine—first used effectively to link rural areas with specialists in urban areas by providing patient services through the use of telecommunications—is evolving.
Initiation of therapy with tocilizumab (Actemra; Genentech) enabled rapid and long-lasting reductions in corticosteroid (CS) use in patients with severe and active rheumatoid arthritis.